Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $528000.0.

  • Jaguar Health's Change in Accured Expenses rose 27087.38% to $528000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 27751.68%. This contributed to the annual value of -$1.1 million for FY2024, which is 6172.59% up from last year.
  • Jaguar Health's Change in Accured Expenses amounted to $528000.0 in Q3 2025, which was up 27087.38% from $1.4 million recorded in Q2 2025.
  • Jaguar Health's 5-year Change in Accured Expenses high stood at $3.3 million for Q1 2022, and its period low was -$6.7 million during Q3 2023.
  • For the 5-year period, Jaguar Health's Change in Accured Expenses averaged around $36684.2, with its median value being $141000.0 (2025).
  • Per our database at Business Quant, Jaguar Health's Change in Accured Expenses soared by 111727.75% in 2021 and then crashed by 572400.0% in 2022.
  • Over the past 5 years, Jaguar Health's Change in Accured Expenses (Quarter) stood at $1.0 million in 2021, then plummeted by 281.01% to -$1.9 million in 2022, then surged by 125.32% to $473000.0 in 2023, then plummeted by 352.85% to -$1.2 million in 2024, then skyrocketed by 144.15% to $528000.0 in 2025.
  • Its last three reported values are $528000.0 in Q3 2025, $1.4 million for Q2 2025, and $141000.0 during Q1 2025.